An HIV Vaccine Targeting the V2 Region of the HIV Envelope Induces a Highly Durable Polyfunctional Fc-Mediated Antibody Response in Rhesus Macaques

The HIV vaccine field now recognizes the potential importance of generating polyfunctional antibodies (Abs). The only clinical HIV vaccine trial to date to show significant efficacy (RV144) found that reduced infection rates correlated with the level of nonneutralizing Abs specific for the V2 region...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:J Virol
मुख्य लेखकों: Powell, Rebecca L., Weiss, Svenja, Fox, Alisa, Liu, Xiaomei, Itri, Vincenza, Jiang, Xunqing, Luo, Christina C., Spencer, David A., Pandey, Shilpi, Cheever, Tracy, Fuller, Deborah H., Totrov, Maxim, Hessell, Ann J., Haigwood, Nancy L., Kong, Xiang-Peng, Zolla-Pazner, Susan
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society for Microbiology 2020
विषय:
Vaccines and Antiviral Agents
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7431793/
https://ncbi.nlm.nih.gov/pubmed/32554699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.01175-20
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन